ArticleCureus2026
Steroid-Resistant Immune Thrombocytopenia With Severe Bleeding Successfully Managed Using Eltrombopag and Mycophenolate in a 67-Year-Old Male.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
A 67-year-old man presented with severe mucocutaneous bleeding and profound thrombocytopenia with a platelet count of 6 × 10³ per microliter. Bone marrow examination showed preserved megakaryocytes, and secondary causes were excluded, confirming primary immune thrombocytopenia (ITP). Despite high-dose intravenous methylprednisolone followed by oral corticosteroids, platelet count remained 8 × 10³ per microliter. Two weeks after the presentation, azathioprine was initiated due to persistent severe thrombocytopenia, and eltrombopag was added. Response remained minimal. One month after the presentation, he was classified as having steroid-refractory disease. Azathioprine was discontinued, and mycophenolate mofetil was started. Platelet count rose steadily, reaching 88 × 10³ per microliter at discharge and normalizing to more than 150 × 10³ per microliter within two weeks, with complete resolution of bleeding. This case highlights the diagnostic challenges of ITP in older adults and supports combining thrombopoietin receptor agonists (TPO-RAs) with targeted immunosuppressive therapy in steroid-refractory disease.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.